Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human PNMT ELISA Kit (AC2782)
Cat.#: ASET-1371
Specifications
Description Human PNMT ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human PNMT concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.75 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1776 Human Synapsin I ELISA Kit (AC3187) Quantitative inquiry ASET-1987 Mouse DCAMKL1 ELISA Kit (AC3398) Quantitative inquiry ASET-1401 Rat Estrogen Receptor beta ELISA Kit (AC2812) Quantitative inquiry ASET-1290 Human Heme Oxygenase 1 ELISA Kit (AC2701) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-1456 Mouse Integrin beta 1 ELISA Kit (AC2867) Quantitative inquiry ASET-1133 Human Neuroglobin ELISA Kit (AC2544) Quantitative inquiry ASET-1195 Human Kallikrein 6 ELISA Kit (AC2606) Quantitative inquiry ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry ASET-1764 Human NRG1 ELISA Kit (AC3175) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket